Search research articles
Contact Us
Filters
Showing results (41-50 of 169) with videos related to
Page
of 17
Sort By:
International Journal of Environmental Research and Public Health
|
January 21, 2022
Individual Perception of Telehealth: Validation of a German Translation of the Telemedicine Perception Questionnaire and a Derived Short Version
Patrick Altmann, Dominik Ivkic, Markus Ponleitner, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
March 10, 2022
Whole brain radiotherapy combined with intrathecal liposomal cytarabine for leptomeningeal metastasis-a safety analysis and validation of the EANO-ESMO classification
Sarah Iglseder, Martha Nowosielski, Gabriel Bsteh, et al.
Plos One
|
July 9, 2016
Long Term Clinical Prognostic Factors in Relapsing-Remitting Multiple Sclerosis: Insights from a 10-Year Observational Study
Gabriel Bsteh, Rainer Ehling, Andreas Lutterotti, et al.
Neurological Research and Practice
|
August 28, 2025
Optical coherence tomography - A possible biomarker in early huntington's disease
Clancy Cerejo, Elias Mandler, Federico Carbone, et al.
Eye and Brain
|
March 19, 2021
Evaluation of Retinal Layer Thickness Parameters as Biomarkers in a Real-World Multiple Sclerosis Cohort
Natascha Schurz, Lydia Sariaslani, Patrick Altmann, et al.
Scientific Reports
|
October 21, 2024
The presence of oligoclonal bands predicts conversion to multiple sclerosis in isolated myelitis
Tobias Monschein, Markus Ponleitner, Gabriel Bsteh, et al.
The Journal of Headache and Pain
|
July 17, 2023
Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension
Nik Krajnc, Bianca Itariu, Stefan Macher, et al.
Scientific Reports
|
October 3, 2024
Investigation of serum neurofilament light chain as a biomarker in Fabry disease
Markus Ponleitner, Constantin Gatterer, Gabriel Bsteh, et al.
Journal of Neurology
|
September 15, 2020
Should I stop or should I go on? Disease modifying therapy after the first clinical episode of multiple sclerosis
Tobias Monschein, Sabine Salhofer-Polanyi, Patrick Altmann, et al.
Cell
|
December 13, 2023
Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosis
Hannes Vietzen, Sarah M Berger, Laura M Kühner, et al.
Page
of 17
Search research articles
Search
Showing results (41-50 of 169) with videos related to
Sort By:
Page
of 17
International Journal of Environmental Research and Public Health
|
January 21, 2022
Individual Perception of Telehealth: Validation of a German Translation of the Telemedicine Perception Questionnaire and a Derived Short Version
Patrick Altmann, Dominik Ivkic, Markus Ponleitner, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
March 10, 2022
Whole brain radiotherapy combined with intrathecal liposomal cytarabine for leptomeningeal metastasis-a safety analysis and validation of the EANO-ESMO classification
Sarah Iglseder, Martha Nowosielski, Gabriel Bsteh, et al.
Plos One
|
July 9, 2016
Long Term Clinical Prognostic Factors in Relapsing-Remitting Multiple Sclerosis: Insights from a 10-Year Observational Study
Gabriel Bsteh, Rainer Ehling, Andreas Lutterotti, et al.
Neurological Research and Practice
|
August 28, 2025
Optical coherence tomography - A possible biomarker in early huntington's disease
Clancy Cerejo, Elias Mandler, Federico Carbone, et al.
Eye and Brain
|
March 19, 2021
Evaluation of Retinal Layer Thickness Parameters as Biomarkers in a Real-World Multiple Sclerosis Cohort
Natascha Schurz, Lydia Sariaslani, Patrick Altmann, et al.
Scientific Reports
|
October 21, 2024
The presence of oligoclonal bands predicts conversion to multiple sclerosis in isolated myelitis
Tobias Monschein, Markus Ponleitner, Gabriel Bsteh, et al.
The Journal of Headache and Pain
|
July 17, 2023
Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension
Nik Krajnc, Bianca Itariu, Stefan Macher, et al.
Scientific Reports
|
October 3, 2024
Investigation of serum neurofilament light chain as a biomarker in Fabry disease
Markus Ponleitner, Constantin Gatterer, Gabriel Bsteh, et al.
Journal of Neurology
|
September 15, 2020
Should I stop or should I go on? Disease modifying therapy after the first clinical episode of multiple sclerosis
Tobias Monschein, Sabine Salhofer-Polanyi, Patrick Altmann, et al.
Cell
|
December 13, 2023
Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosis
Hannes Vietzen, Sarah M Berger, Laura M Kühner, et al.
Page
of 17